Virax Biolabs (VRAX) Falls 18% on Lack of Leads

Post Content
Stay informed with expert takes on business strategy, investing, entrepreneurship, and global markets. CurioAtlas brings you articles that guide smarter decisions in finance and business growth.

Post Content
The AI-infrastructure company’s stock has been hammered on concerns over losses and debt. But CoreWeave is a “best-in-class” player whose shares could climb to $116, one analyst said.

Post Content

Post Content

The “hushed hybrid” trend of workers bucking RTO mandates to work from home some days anyways is going strong, according to fresh data from Flex Index. Beyond workers defying policies because they feel as if it’s not practical, managers are…
Post Content
Post Content

Kohl’s has had a challenging year marked by leadership turmoil and declining sales. But its second-quarter earnings report surprised analysts. In Q2, Kohl’s posted adjusted earnings per share of $0.56, significantly exceeding the expected $0.30, leading to nearly a 20%…
Post Content
The home-goods giant boosted its sales outlook on stronger sales of furniture and nonfurniture items, but it cautioned about tariff uncertainties.